HOME >> MEDICINE >> NEWS
LIALDA -- the first oral once-daily mesalamine for ulcerative colitis -- now available

Basingstoke, UK and Philadelphia, PA, US March 19, 2007 Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) today announced the availability of LIALDA (mesalamine) with MMXTM Technology, indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis (UC), a type of inflammatory bowel disease. LIALDA is the first and only FDA-approved once daily oral formulation of mesalamine. The U.S. Food and Drug Administration (FDA) approved LIALDA on January 16, 2007.

LIALDA is available to patients by prescription for oral administration in dosages of 2.4 g/day and 4.8 g/day, allowing patients to take as few as two tablets once daily. Other currently available mesalamines require three to four times daily dosing and six to 16 pills a day. A study found that patients who are not compliant with their mesalamine medications have a five-fold greater risk of disease flares, a serious worsening of symptoms, than compliant patients.

"In clinical trials, LIALDA was superior to placebo in inducing remission. Additionally, LIALDA's convenient once daily dosing may help address the compliance issues facing so many ulcerative colitis patients," said Mike Cola, President of Shire's Specialty Pharmaceuticals business. "Shire is pleased to offer this latest advancement in the treatment of ulcerative colitis, which complements our existing GI portfolio and reinforces our commitment to improving the treatment of gastrointestinal diseases."

"Although not everyone's experience is the same, taking the pills for my disease seemed to consume my life - my next dosage was constantly on my mind," said Becky Pace, a LIALDA clinical trial patient. "I could not believe taking medication once a day would help as much as it did. LIALDA brought my disease into remission."

About LIALDA

LIALDA is part of a drug class called aminosalicylates, which contain 5-aminosalicyclic acid (5-ASA). 5-ASA is a well-established dr
'"/>

Contact: Lisa Koen
lkoen@golinharris.com
Shire plc
19-Mar-2007


Page: 1 2 3

Related medicine news :

1. Ulcerative colitis remission rates from long-term safety study of LIALDA presented at DDW
2. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
3. Worcester Polytechnic Institute to host national forum on locating first responders inside buildings
4. Screening for behavioral health first step to getting treatment
5. Polish journalist scoops first prize in prestigious European award
6. Poker match pits an vs. machine in world first match
7. Dasatinib shows high early response rate as first treatment for chronic myelogenous leukemia
8. World first medical treatment announced by researchers
9. Long-term treatment with VYVANSE, first prodrug stimulant, demonstrates significant efficacy in ADHD
10. A first glimpse at healthy brain and behavioral development
11. UPMC performs first beating heart transplant procedure in the US

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2020)... ... September 01, 2020 , ... Feeding Matters , the first ... Pediatric Feeding Disorder (PFD), is pleased to announce that the U.S. Centers for Disease ... (R code) in the next edition of the U.S. International Classification of Diseases ...
(Date:8/31/2020)... ... 2020 , ... Just found out your dear friend has cancer? , It’s hard to hear ... member shares their diagnosis. Once the shock wears off, the questions and fears can be ... the best ways to help? Words are failing me. I’m scared. I want to DO ...
(Date:8/31/2020)... ... August 31, 2020 , ... Smile Brands Inc., ... in the United States, today announced the grand opening of another affiliated ... Patients will enjoy convenient hours, a comfortable office, and full-service care at the ...
(Date:8/31/2020)... ... August 31, 2020 , ... Bonde ... for patients with advanced heart failure, today announced that the company has been ... of $555,358 from the National Heart, Lung, and Blood Institute of the National ...
(Date:8/28/2020)... ... August 28, 2020 , ... With ... set out to continue helping the specialty-diet community connect with great, gluten-free brands. ... get coupons, enter giveaways, chat with brands & watch over 50 educational classes... ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... and ROCKWALL, Texas (PRWEB) , ... ... ... Powerful Preventative in the Fight Against Covid-19 , Advanced Penetration Technology, LLC, ... innovative healthcare solutions for patients utilizing non-prescription, Over The Counter (OTC) products, ...
(Date:9/1/2020)... ... September 01, 2020 , ... ... appointed to serve as Secretary to the Board of Trustees and committee chair ... High United Way is a Denver-based nonprofit organization that fights for the education, ...
(Date:8/31/2020)... AVIV, Israel (PRWEB) , ... August 31, 2020 ... ... to specialize in wellness-related technologies, today announced that they have invested $400,000 in ... competition that ran in collaboration with the Global Wellness Institute (GWI). , ...
Breaking Medicine Technology:
Cached News: